Valuation Virax Biolabs Group Limited

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/04/2026 BST			5-day change	1st Jan Change
0.1349 ^USD	-10.07%		-22.47%	-60.99%

03-18	Virax Biolabs Group Limited Approves Fourth Amended and Restated Memorandum and Articles of Association	CI
12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2023	2024	2025	2026	2027
Capitalization ¹	10.81	1.693	4.95	1.001	-
Change	-	-84.34%	192.29%	-79.77%	-
Enterprise Value (EV)	10.81	1.693	4.95	1.001	1.001
Change	-	-84.34%	192.29%	-79.77%	0%
P/E ratio	-	-0.21x	-0.7x	-0.34x	-0.56x
PBR	-	-	-	-	-
PEG	-	-	0x	0x	0x
Capitalization / Revenue	1,263x	-	782x	250x	250x
EV / Revenue	0x	-	0x	250x	250x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-	-0x	-0.19x	-0.19x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-3.36	-1.62	-0.4	-0.24
Distribution rate	-	-	-	-	-
Net sales ¹	0.00856	-	0.00633	0.004	0.004
EBITDA	-5.733	-	-	-	-
EBIT ¹	-5.733	-	-6.163	-5.184	-5.198
Net income ¹	-5.457	-6.734	-6.061	-4.942	-5.198
Net Debt	-	-	-	-	-
Reference price ²	6.9540	0.7170	1.1400	0.1349	0.1349
Nbr of stocks (in thousands)	1,555	2,362	4,342	7,423	-
Announcement Date	14/06/23	20/08/24	02/07/25	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VIRAX BIOLABS GROUP LIMITED	-0.34x	-	-	-	1M
LONZA GROUP AG	30.82x	5.41x	16.69x	1.07%	44.74B
BEONE MEDICINES AG	56.65x	4.9x	32.92x	-.--%	34.75B
CELLTRION, INC.	33.82x	8.64x	22.14x	0.37%	29.82B
IQVIA HOLDINGS INC.	20.91x	2.4x	10.34x	-.--%	28.37B
REVOLUTION MEDICINES, INC.	-12.54x	325.95x	-10.61x	-.--%	19.07B
ASCENDIS PHARMA A/S	49.76x	8.84x	27.57x	-.--%	14.93B
MEDPACE HOLDINGS, INC.	29.3x	4.75x	21.57x	-.--%	14.32B
EUROFINS SCIENTIFIC SE	21.56x	1.91x	8.38x	1.18%	13.17B
Average	25.55x	45.35x	16.13x	0.33%	22.13B
Weighted average by Cap.	30.91x	36.04x	17.44x	0.37%